ASXL1 inactivation and reduced H3K27me3 across central nervous system tumors Research Letter
| Authors: | Zhang, K. Y.; Parker, M.; Weber-Levine, C.; Kalluri, A.; Gonzalez-Gomez, I.; Raabe, E.; Dudley, J. C.; Gocke, C.; Lin, M. T.; Zou, Y.; Sherief, M.; Kamson, D. O.; Holdhoff, M.; Mukherjee, D.; Croog, V.; Schreck, K. C.; Rincon-Torroella, J.; Bettegowda, C.; Eberhart, C. G.; Bale, T.; Lucas, C. H. G. |
| Title: | ASXL1 inactivation and reduced H3K27me3 across central nervous system tumors |
| Keywords: | immunohistochemistry; adult; clinical article; controlled study; human tissue; young adult; gene mutation; promoter region; exon; frameshift mutation; gene deletion; genetics; missense mutation; glioma; letter; metabolism; gene; gene amplification; cohort analysis; pathology; central nervous system tumor; central nervous system neoplasms; carcinogenesis; histone; glioblastoma; histone h3; medulloblastoma; ependymoma; oligodendroglioma; gene inactivation; meningioma; repressor protein; repressor proteins; histones; nonsense mutation; posterior cranial fossa tumor; asxl1 gene; splicing defect; pilocytic astrocytoma; high throughput sequencing; epigenetic modification; asxl1 protein, human; humans; human; male; female |
| Journal Title: | Acta Neuropathologica |
| Volume: | 148 |
| ISSN: | 0001-6322 |
| Publisher: | Springer |
| Date Published: | 2024-08-14 |
| Start Page: | 19 |
| Language: | English |
| DOI: | 10.1007/s00401-024-02785-z |
| PUBMED: | 39141113 |
| PROVIDER: | scopus |
| PMCID: | PMC11324662 |
| DOI/URL: | |
| Notes: | Letter -- Source: Scopus |
